By Mike Scarcella Jan 30 (Reuters) - Alphabet's Google persuaded a federal judge in San Francisco on Friday to reject a bid ...
If approved, MEA would build three stations along the Seward Meridian.
Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding factor for undergoing symptom-relieving therapies.
Better late than never, right? Look, we know it’s late January. Most people have already abandoned their New Year’s resolutions, and the wearables world is already whispering about what’s coming later ...
Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized treatments. Learn more.
Paleyfest LA, celebrating the most acclaimed shows on tv, returns this spring with the biggest stars and the hottest shows, ...
India will shift to a new Consumer Price Index series with 2024 as the base year from 12 February 2026, after an expert group ...
Online rumors assert that Ring's partnership with Flock, which manages systems used by law enforcement, allow ICE access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results